INR 891.75
(2.58%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 1.8 Billion INR | 28.96% |
2022 | 1.39 Billion INR | 6.68% |
2021 | 1.31 Billion INR | 22.85% |
2020 | 1.06 Billion INR | 12.28% |
2019 | 951.12 Million INR | 11.07% |
2018 | 856.29 Million INR | 9.99% |
2017 | 778.51 Million INR | 8.76% |
2016 | 715.79 Million INR | 10.58% |
2015 | 647.33 Million INR | 14.65% |
2014 | 564.63 Million INR | 12.68% |
2013 | 501.11 Million INR | 14.13% |
2012 | 439.08 Million INR | 0.0% |
2010 | 381.43 Million INR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 563 Million INR | 13.43% |
2023 FY | 1.8 Billion INR | 28.96% |
2023 Q4 | 496.35 Million INR | 5.76% |
2023 Q1 | 386.48 Million INR | 4.88% |
2023 Q2 | 452.73 Million INR | 17.14% |
2023 Q3 | 469.31 Million INR | 3.66% |
2022 Q3 | 349.65 Million INR | -10.23% |
2022 FY | 1.39 Billion INR | 6.68% |
2022 Q1 | 291.91 Million INR | -6.85% |
2022 Q2 | 389.5 Million INR | 33.43% |
2022 Q4 | 368.48 Million INR | 5.39% |
2021 Q1 | 334.43 Million INR | 9.33% |
2021 FY | 1.31 Billion INR | 22.85% |
2021 Q4 | 313.36 Million INR | 1.0% |
2021 Q3 | 310.24 Million INR | -12.33% |
2021 Q2 | 353.88 Million INR | 5.81% |
2020 FY | 1.06 Billion INR | 12.28% |
2020 Q1 | 175.49 Million INR | -23.96% |
2020 Q2 | 281.66 Million INR | 60.5% |
2020 Q3 | 304.82 Million INR | 8.22% |
2020 Q4 | 305.9 Million INR | 0.35% |
2019 FY | 951.12 Million INR | 11.07% |
2019 Q4 | 230.79 Million INR | -7.92% |
2019 Q2 | 252.87 Million INR | 16.63% |
2019 Q1 | 216.81 Million INR | 5.26% |
2019 Q3 | 250.63 Million INR | -0.88% |
2018 Q4 | 205.99 Million INR | -5.35% |
2018 FY | 856.29 Million INR | 9.99% |
2018 Q3 | 217.64 Million INR | 0.0% |
2017 FY | 778.51 Million INR | 8.76% |
2016 Q1 | 176.12 Million INR | 0.0% |
2016 FY | 715.79 Million INR | 10.58% |
2015 FY | 647.33 Million INR | 14.65% |
2014 FY | 564.63 Million INR | 12.68% |
2013 FY | 501.11 Million INR | 14.13% |
2012 FY | 439.08 Million INR | 0.0% |
2010 FY | 381.43 Million INR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Biocon Limited | 147.55 Billion INR | 98.777% |
Blue Jet Healthcare Limited | 7.11 Billion INR | 74.636% |
Concord Biotech Limited | 9.98 Billion INR | 81.916% |
Dishman Carbogen Amcis Limited | 26.15 Billion INR | 93.1% |
Jubilant Ingrevia Limited | 41 Billion INR | 95.598% |
Lyka Labs Limited | 1.05 Billion INR | -71.677% |
Panacea Biotec Limited | 5.59 Billion INR | 67.722% |
Piramal Pharma Limited | 81.71 Billion INR | 97.791% |
SMS Lifesciences India Limited | 3.05 Billion INR | 41.009% |
Supriya Lifescience Limited | 5.7 Billion INR | 68.356% |
Syngene International Limited | 34.88 Billion INR | 94.826% |
TAKE Solutions Limited | 656.08 Million INR | -175.101% |